Skip to main content
Clinical Trials/NCT05758909
NCT05758909
Active, not recruiting
Not Applicable

Evaluation of the Viability and Safety of Early Discharge Protocol After TAVI Implantation

Fundación EPIC13 sites in 1 country585 target enrollmentApril 4, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Aortic Valve Disease
Sponsor
Fundación EPIC
Enrollment
585
Locations
13
Primary Endpoint
Assessment of early safety
Status
Active, not recruiting
Last Updated
4 months ago

Overview

Brief Summary

Evaluation of the safety and efficacy of early discharge (24 hours) after transfemoral transcatheter aortic prosthesis implantation (TAVI).

Detailed Description

Evaluation of the safety and efficacy of early discharge (24 hours) after transfemoral transcatheter aortic prosthesis implantation (TAVI).

Registry
clinicaltrials.gov
Start Date
April 4, 2023
End Date
December 1, 2026
Last Updated
4 months ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Fundación EPIC
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients who meet all of the following conditions will be included:
  • Patients ≥ 18 years undergoing transfemoral TAVI implantation scheduled, performed on an outpatient basis.
  • Patients with percutaneous implant.
  • Patients undergoing the procedure under superficial sedation or Local anesthesia.
  • Patients with baseline narrow QRS that does not change after implantation, or definitive pacemaker carrier.
  • Patients who have signed the informed consent.

Exclusion Criteria

  • Patients who do not meet any of the following conditions:
  • Patients with a wide QRS (greater than or equal to 120 msec) at baseline, with the except for patients with permanent pacemakers.
  • Hospitalized patients undergoing urgent TAVI implantation.
  • Patients with access other than percutaneous transfemoral.

Outcomes

Primary Outcomes

Assessment of early safety

Time Frame: 30 days

Proportion of patients with early safety defined as: * Cardiovascular death. * Stroke. * Myocardial Infarction. * Hospitalization for any reason . * Major vascular complications. * Need for pacemakers.

Secondary Outcomes

  • Assessment of Hospitalization for any reason(12 months)
  • Assessment of Stroke(12 months)
  • Assessment of Myocardial Infarction(12 months)
  • Assessments of need for pacemakers(12 months)
  • Assessment of Cardiovascular death(12 months)
  • Assessments of Major Vascular Complications(12 months)
  • Assessment of hospitalization time(at discharge)
  • Assessment of hospitalization due cardiac reasons(30 days)

Study Sites (13)

Loading locations...

Similar Trials